Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 0 | 0 | 0 | 3 | 3 |
| Gross Profit | N/A | N/A | N/A | 3 | 3 |
| Operating Expenses | 3,843 | 3,171 | 3,273 | 3,331 | 3,249 |
| Operating Income | -3,843 | -3,171 | -3,273 | -3,328 | -3,245 |
| Other Income | 69 | 49 | -1 | 2 | 0 |
| Pre-tax Income | -3,773 | -3,122 | -3,274 | -3,326 | -3,245 |
| Net Income Continuous | -3,773 | -3,122 | -3,274 | -3,326 | -3,245 |
| Net Income Discontinuous | -545 | -23 | -61 | N/A | N/A |
| Net Income | $-4,318 | $-3,145 | $-3,335 | $-5,813 | $-3,245 |
| EPS Basic Total Ops | -28.09 | -19.80 | -23.40 | -45.00 | -23.40 |
| EPS Basic Continuous Ops | -24.49 | -20.29 | -23.40 | -26.72 | -23.81 |
| EPS Basic Discontinuous Ops | -3.60 | -0.15 | -0.44 | N/A | N/A |
| EPS Diluted Total Ops | -28.09 | -19.80 | -23.40 | -45.00 | -23.40 |
| EPS Diluted Continuous Ops | -24.49 | -20.29 | -23.40 | -26.72 | -23.81 |
| EPS Diluted Discontinuous Ops | -3.60 | -0.15 | -0.44 | N/A | N/A |
| EBITDA(a) | $-3,730 | $-3,180 | $-3,208 | $-3,229 | $-3,117 |